Reyon Pharmaceutical Co., Ltd.

Reyon Pharmaceutical is a South Korean pharmaceutical company established in 1955. It specializes in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished drug products such as injections, antibiotics, and specialty medicines. In recent years, the company has pivoted toward next-generation biopharmaceuticals, including gene therapy, cell therapy, and mRNA-based therapeutics. It operates advanced manufacturing facilities, including a significant biomanufacturing plant in Chungju, and actively engages in joint R&D and licensing partnerships to expand its pipeline in oncology and rare diseases.